Report on the Third Symposium "cCMP and cUMP as New Second Messengers"

Naunyn Schmiedebergs Arch Pharmacol. 2015 Jan;388(1):1-3. doi: 10.1007/s00210-014-1072-3. Epub 2014 Dec 4.

Abstract

The cyclic pyrimidine nucleotides cytidine 3',5'-cyclic monophosphate (cCMP) and uridine 3',5'-cyclic monophosphate (cUMP) have been unequivocally identified in mammalian cells using the most advanced mass spectrometry methods. On October 10, 2014, leading experts in the field met at the Hannover Medical School, Hannover, Germany, to discuss the latest findings in this emerging field of research. Generators, effectors, biological functions, inactivation mechanisms, and model systems for cCMP and cUMP were discussed. Pseudomonas aeruginosa nucleotidyl cyclase toxin ExoY, effectively producing cUMP, was a central topic of the meeting. cCMP and cUMP fulfill the criteria for second messengers. Future research directions in the field will include the identification of specific effector proteins of cCMP and cUMP, new cCMP- and cUMP-generating bacterial toxins, the analysis of new model organisms such as the zebra fish, and elucidation of the function of other noncanonical cyclic nucleotides such as inosine 3',5'-cyclic monophosphate (cIMP).

Publication types

  • Congress

MeSH terms

  • Animals
  • Cyclic CMP / metabolism*
  • Nucleotides, Cyclic / metabolism*
  • Second Messenger Systems*
  • Uridine Monophosphate / metabolism*

Substances

  • Nucleotides, Cyclic
  • Cyclic CMP
  • cyclic 3',5'-uridine monophosphate
  • Uridine Monophosphate